Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

The patches could quickly deliver epilepsy treatment and reduce seizures.

A combination of oral cyclosporin and PUVA treatment worked well for a severe skin condition called generalized pustular psoriasis.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

AVT is highly conserved and may have antimicrobial properties.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

The FDA did not approve a testosterone drug because of safety concerns.

Extended-release valproate effectively reduced seizures and improved quality of life in epilepsy patients over 6 months, with some side effects.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

A heart transplant patient developed a skin condition called epidermodysplasia verruciformis after taking immune-suppressing drugs.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

TrichoSolTM is safe for hair loss treatments with specific ingredient stability for up to 180 days.

Divalproex sodium can cause pleural effusion, which stops when the drug is discontinued.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

A specific gene mutation (Y449H in K10) was found in a patient with severe skin disorder.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.